Preprint · 2026 · Open access
ClickChem: Automated Conjugation Chemistry Planning for Antibody–Drug Conjugates
ChemRxiv · Published 21 May 2026 · DOI 10.26434/chemrxiv.15003698/v1
In brief
“ClickChem: Automated Conjugation Chemistry Planning for Antibody–Drug Conjugates” is a 2026 preprint by Vicent Ribas and Vicent Ribas Ripoll, published in ChemRxiv. OpenAlex counts 0 citations as of 21 November 2026. It is open access under a CC BY-NC-ND licence: the full text is free to read at ChemRxiv.
- Citations
- 0
- Authors
- 2
Abstract
Antibody–drug conjugates (ADCs) require precise conjugation chemistry to covalently attach cytotoxic payloads to monoclonal antibodies while preserving antigen-binding function and pharmacokinetic stability. The selection of an appropriate conjugation strategyencompassing the reaction family, the conjugation site on the antibody, and the linker architecture—remains largely empirical, relying on iterative experimental screens that are costly and time-consuming. We present ClickChem, a computational pipeline that auto-mates conjugation chemistry selection for ADC design. The pipeline operates in six sequential stages: functional-group detection on the payload, multi-conformer solvent-accessible surface area (SASA) scoring of antibody conjugation sites, chemistry family planning across seven reaction families, linker selection from a curated library, in silico bond formation via SMIRKSbased reaction execution, and product validation through a six-layer quality-control protocol incorporating Maximum Common Substructure (MCS) analysis. A distinguishing feature of the site-scoring module is an ensemble-averaged SASA calculation that generates multiple antibody conformations through an Anisotropic Network Model (ANM) and aggregates solvent-exposure statistics across the ensemble, yielding a confidence metric that penalises residues whose accessibility fluctuates between conformations. We evaluate the pipeline on three fronts. First, we verify concordance with established clinical precedent by exercising the pipeline on the payloads and conjugation-site annotations of ten FDA-approved ADCsincluding Adcetris, Kadcyla, Enhertu, and Trodelvy—and show that the pipeline selects the conventionally employed reaction family in all ten cases (10/10 concordance). Second, we present two end-to-end case studies—MMAF and Doxorubicin conjugated to a full-length IgG surrogate (PDB: 1IGT) via heterobifunctional SPAAC–IEDDA dual-click chemistrydemonstrating handle installation, site-specific conjugation at three distinct residue types
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Ribas, V., & Ripoll, V. R. (2026). ClickChem: Automated Conjugation Chemistry Planning for Antibody–Drug Conjugates. ChemRxiv. https://doi.org/10.26434/chemrxiv.15003698/v1
MLA 9
Ribas, Vicent, and Vicent Ribas Ripoll. “ClickChem: Automated Conjugation Chemistry Planning for Antibody–Drug Conjugates.” ChemRxiv, 2026. https://doi.org/10.26434/chemrxiv.15003698/v1.
Chicago
Ribas, Vicent and Vicent Ribas Ripoll. 2026. “ClickChem: Automated Conjugation Chemistry Planning for Antibody–Drug Conjugates.” ChemRxiv. https://doi.org/10.26434/chemrxiv.15003698/v1.
Harvard
Ribas, V. and Ripoll, V. R. (2026) ‘ClickChem: Automated Conjugation Chemistry Planning for Antibody–Drug Conjugates’, ChemRxiv. doi:10.26434/chemrxiv.15003698/v1.
IEEE
V. Ribas and V. R. Ripoll, “ClickChem: Automated Conjugation Chemistry Planning for Antibody–Drug Conjugates,” ChemRxiv, 2026, doi: 10.26434/chemrxiv.15003698/v1.
BibTeX
@misc{ribas2026clickchem,
title = {{ClickChem: Automated Conjugation Chemistry Planning for Antibody–Drug Conjugates}},
author = {Ribas, Vicent and Ripoll, Vicent Ribas},
howpublished = {ChemRxiv},
year = {2026},
doi = {10.26434/chemrxiv.15003698/v1},
url = {https://doi.org/10.26434/chemrxiv.15003698/v1}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- antibody-drug conjugates
- solvent accessible surface area
- anisotropic network model
- maximum common substructure
- monomethyl auristatin F
Work with this paper
Most-cited papers in Pharmacology, Toxicology and Pharmaceutics
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingOleg Trott, Arthur J. Olson · Journal of Computational Chemistry · 2009 · 39,860 citations
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityGarrett M. Morris, Ruth Huey, William Lindstrom and 4 more · Journal of Computational Chemistry · 2009 · 26,508 citations
- Development and testing of a general amber force fieldJunmei Wang, Romain M. Wolf, James W. Caldwell and 2 more · Journal of Computational Chemistry · 2004 · 20,080 citations
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1Christopher A. Lipinski, Franco Lombardo, Beryl W. Dominy and 1 more · Advanced Drug Delivery Reviews · 2001 · 19,638 citations
- SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small moleculesAntoine Daina, Olivier Alain Michielin, Vincent Zoete · Scientific Reports · 2017 · 19,557 citations
All highly cited Pharmacology, Toxicology and Pharmaceutics papers
Questions about this paper
How do I cite this paper in APA style?
Ribas, V., & Ripoll, V. R. (2026). ClickChem: Automated Conjugation Chemistry Planning for Antibody–Drug Conjugates. ChemRxiv. https://doi.org/10.26434/chemrxiv.15003698/v1
How many times has this paper been cited?
0 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at ChemRxiv: sign in and open the full text from this page.
Who wrote this paper?
Vicent Ribas, Vicent Ribas Ripoll.
What is the DOI of this paper?
10.26434/chemrxiv.15003698/v1, permanently at https://doi.org/10.26434/chemrxiv.15003698/v1. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.